Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Assessing unintended hybridization-induced biological effects of oligonucleotides

Nature Biotechnology volume 30, pages 920–923 (2012)Cite this article

Subjects

To the Editor:

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Assessment of hybridization-based off-target effects starts with a mechanism- and chemistry-dependent in silico screen, which is interpreted and validated on a case-by-case basis using auxiliary information and experiments.

References

  1. Zamecnik, P.C. & Stephenson, M.L. Proc. Natl. Acad. Sci. USA 75, 280–284 (1978).

    Article  CAS  Google Scholar 

  2. Fire, A. et al. Nature 391, 806–811 (1998).

    Article  CAS  Google Scholar 

  3. Henry, S. et al. Toxicologic properties of 2′-methoxyethyl chimeric antisense inhibitors in animals and man. in Antisense Drug Technology: Principles Strategies, and Applications. (ed. Crooke, S.T.) 327–364 (CRC Press, 2007).

    Google Scholar 

  4. Sheehan, J.P. & Phan, T.M. Biochemistry 40, 4980–4989 (2001).

    Article  CAS  Google Scholar 

  5. Bennett, C.F. & Swayze, E.E. Annu. Rev. Pharmacol. Toxicol. 50, 259–293 (2010).

    Article  CAS  Google Scholar 

  6. Burchard, J. et al. RNA 15, 308–315 (2009).

    Article  CAS  Google Scholar 

  7. Jackson, A.L. et al. RNA 12, 1179–1187 (2006).

    Article  CAS  Google Scholar 

  8. Snøve, O. & Holen, T. Biochem. Biophys. Res. Commun. 319, 256–263 (2004).

    Article  Google Scholar 

  9. Jackson, A.L. et al. Nat. Biotechnol. 21, 635–637 (2003).

    Article  CAS  Google Scholar 

  10. Schwarz, D.S. et al. PLoS Genet. 2, e140 (2006).

    Article  Google Scholar 

  11. Obad, S. et al. Nat. Genet. 43, 371–378 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Santaris Pharma A/S, Hørsholm, Denmark

    Morten Lindow

  2. Axolabs GmbH, Kulmbach, Germany

    Hans-Peter Vornlocher

  3. DNA Consulting LLC, Ellensburg, Washington, USA

    Donald Riley

  4. Preclinsight, Reno, Nevada, USA

    Douglas J Kornbrust

  5. Merck & Co., Inc., West Point, Pennsylvania, USA

    Julja Burchard

  6. Pfizer, Cambridge, Massachusetts, USA

    Laurence O Whiteley

  7. RXi, Worcester, Massachusetts, USA

    Joanne Kamens

  8. Quark Pharmaceuticals, Boulder, Colorado, USA

    James D Thompson

  9. Alnylam Therapeutics, Cambridge, Massachusetts, USA

    Saraswathy Nochur

  10. Isis Pharmaceuticals, Carlsbad, California, USA

    Husam Younis & Scott P Henry

  11. Merck & Co., Inc., Palo Alto, California, USA

    Steven Bartz

  12. GlaxoSmithKline R&D, Ware, Hertfordshire, UK

    Joel Parry

  13. Topigen Pharmaceuticals, Pharmaxis Ltd., Montreal, Quebec, Canada

    Nicolay Ferrari

  14. miRagen Therapeutics, Boulder, Colorado, USA

    Arthur A Levin

Authors
  1. Morten Lindow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans-Peter Vornlocher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Donald Riley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Douglas J Kornbrust
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Julja Burchard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laurence O Whiteley
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joanne Kamens
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. James D Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Saraswathy Nochur
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Husam Younis
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Steven Bartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Joel Parry
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Nicolay Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Scott P Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Arthur A Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur A Levin.

Ethics declarations

Competing interests

The authors are employees in, or consultants for, commercial companies actively developing oligonucleotides as drugs. See affiliation section for details.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lindow, M., Vornlocher, HP., Riley, D. et al. Assessing unintended hybridization-induced biological effects of oligonucleotides. Nat Biotechnol 30, 920–923 (2012). https://doi.org/10.1038/nbt.2376

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2376

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research